CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint | Nature Communications
Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint - eBioMedicine
Cancers | Free Full-Text | CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors | PNAS
CD73, What a Powerful Therapy Target in Tumor Immune
Biomarkers Testing for Bladder Cancer - Enzo Life Sciences
The elegant complexity of mammalian ecto-5′-nucleotidase (CD73): Trends in Cell Biology
Cancers | Free Full-Text | Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles
Cancers | Free Full-Text | Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers
CD73 is a hypoxia-responsive gene and promotes the Warburg effect of human gastric cancer cells dependent on its enzyme activity
Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities: Trends in Cancer
Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint - eBioMedicine
Targeting the CD73-adenosine axis in immuno-oncology - ScienceDirect
Frontiers | Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E
Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy | Journal for ImmunoTherapy of Cancer
IJMS | Free Full-Text | CD39 Regulation and Functions in T Cells
Extracellular ATP and adenosine in tumor microenvironment: Roles in epithelial–mesenchymal transition, cell migration, and invasion - Alvarez - 2022 - Journal of Cellular Physiology - Wiley Online Library
Cancers | Free Full-Text | Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers
Frontiers | Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
![PDF] Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2538dfb30daa57e7af8664d62d1fce4b79216bdd/2-Figure1-1.png "PDF] Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review. | Semantic Scholar")
PDF] Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review. | Semantic Scholar
Frontiers | Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
IJMS | Free Full-Text | Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39 | Journal of Medicinal Chemistry
Targeting immunosuppressive adenosine in cancer | Nature Reviews Cancer
Targeting CD73 to augment cancer immunotherapy - ScienceDirect
CD73, What a Powerful Therapy Target in Tumor Immune
